Evidence map›Paper›PMID 38433940›Full record

ArticleRSC advances2024

Rifampicin adsorption and release study using Santa Barbara amorphous-16 modified Al (SBA-16-Al) for a drug delivery system.

Maria Christina Prihatiningsih, Chaidir Pratama, Noor Anis Kundari, Kartini Megasari, Dhita Ariyanti, Andri Saputra, Hersandy Dayu Kusuma, Puji Astuti

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Maria Christina PrihatiningsihPolytechnic Institute of Nuclear Technology, National Research and Innovation Agency (BRIN) Yogyakarta Indonesia maria.christina@polteknuklir.ac.id mari003@brin.go.id.ORCID https://orcid.org/0000-0002-9614-6754
Chaidir PratamaResearch Center for Radioisotope, Radiopharmaceutical, and Biodosimetry Technology, Research Organization of Nuclear Energy, National Research and Innovation Agency (BRIN) Indonesia.ORCID https://orcid.org/0000-0002-1812-0882
Noor Anis KundariPolytechnic Institute of Nuclear Technology, National Research and Innovation Agency (BRIN) Yogyakarta Indonesia maria.christina@polteknuklir.ac.id mari003@brin.go.id.
Kartini MegasariPolytechnic Institute of Nuclear Technology, National Research and Innovation Agency (BRIN) Yogyakarta Indonesia maria.christina@polteknuklir.ac.id mari003@brin.go.id.
Dhita AriyantiPolytechnic Institute of Nuclear Technology, National Research and Innovation Agency (BRIN) Yogyakarta Indonesia maria.christina@polteknuklir.ac.id mari003@brin.go.id.
Andri SaputraDepartment of Rubber and Plastic Processing Technology, Politeknik ATK Yogyakarta Indonesia.ORCID https://orcid.org/0000-0002-8102-8069
Hersandy Dayu KusumaDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran Jl. Raya Bandung - Sumedang KM. 21 Jatinangor Sumedang 45363 Indonesia.ORCID https://orcid.org/0000-0002-8428-3006
Puji AstutiPolytechnic Institute of Nuclear Technology, National Research and Innovation Agency (BRIN) Yogyakarta Indonesia maria.christina@polteknuklir.ac.id mari003@brin.go.id.
National Nuclear Energy Agency of Indonesia · IDPadjadjaran University · IDUniversitas Teknologi Yogyakarta · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, the surface modification of Santa Barbara Amorphous-16 (SBA-16) with aluminum (SBA-16-Al) was carried out as a rifampicin matrix for the treatment of tuberculosis. Surface modification of SBA-16 was achieved using the direct-synthesis grafting method. Then, the adsorption and release properties of rifampicin from the SBA-16-Al matrix have been studied in batches. In addition, the SBA-16-Al has been characterized using Fourier-Transform Infrared Spectroscopy (FTIR), X-ray diffraction analysis (XRD), transmission electron microscopy (TEM), and Surface Area Analysis (SAA) Brunaur, Emmett and Teller (SAA-BET). The results show that the mesoporous material, the SBA-16-Al has a specific surface area of 843.5 m

Identifiers

PMID38433940
PMCPMC10906368
OpenAlexW4392396419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.